China’s Abrupt Covid Pivot Leaves Many Without Medicines
Millions are desperate to get their hands on fever-reducing drugs and antivirals such as Pfizer’s Paxlovid as infections across China outpace supplies.
They Created a Drug for Susannah. What About Millions of Other Patients?
Scientists have made rapid progress in customizing drugs for ultrarare diseases. The hard part now is making such treatments on a large scale.
What Medicines to Stock for the ‘Tripledemic’ Cold and Flu Season
Doctors weigh in on the essentials families need and what parents can do if they’re unable to find children’s pain reliever.
Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?
Shortages and drug-resistant germs have renewed attention on a $6 billion proposal in Congress that would reconfigure the way antimicrobial drugs are developed and sold.
Los bloqueadores de pubertad pueden ayudar a menores trans. ¿A qué costo?
Los bloqueadores de la pubertad pueden aliviar la angustia de los menores trans y ganar tiempo para sopesar las opciones. Pero las preocupaciones sobre los efectos físicos a largo plazo y otras consecuencias van en aumento.
As Covid Spreads Fast in China, Beijing Isn’t in Lockdown. But It Feels Like It.
Almost no one is venturing out even after an easing of pandemic measures. Cold and flu medicines are scarce, but food supplies appear adequate.
Global Partners May End Broad Covid Vaccination Effort in Developing Countries
The board of Gavi, the international vaccine agency, meets Wednesday to debate shutting down the program, known as Covax, amid swiftly waning demand for the shots.
Countries Need to Make Their Own Vaccines. Why Isn’t the U.S. Embracing This Pandemic Prevention Strategy?
Every region of the world must be able to make its own vaccines.
Alzheimer’s APOE4 Genetic Risk Targeted in Promising Trial
Preliminary results offer hope that gene therapy can protect people with a version of the brain disease driven by a particular gene variant.
Alzheimer’s Drug May Benefit Some Patients, New Data Shows
The drug, lecanemab, made by Eisai and Biogen, also carried risks of brain swelling and bleeding and should be studied further, a report of the findings said.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.